Novadaq Technologies Inc (NASDAQ:NVDQ) shares are rising close to 5% as the medical imaging solutions maker stands to benefit from receiving reimbursement coverage from …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has analysts on the fence after clearing a big hurdle: a big FDA win for its psoriasis drug …
In a research report issued Wednesday, Canaccord’s top analyst Richard Davis reiterated a Buy rating on shares of Shopify Inc (NYSE:SHOP), while raising the …
Canaccord analyst Robert Burleson believes 2018 will be the year of iRobot Corporation (NASDAQ:IRBT) as home robots begin to capture market share and …
Top analyst Michael Walkley at Canaccord sees bullish forecasts ahead for Apple Inc. (NASDAQ:AAPL) and QUALCOMM, Inc.
Canaccord’s top analyst Michael Walkley is out with a research note on shares of Nokia Corp (ADR) (NYSE:NOK), after the mobile equipment maker released solid …
Canaccord’s top analyst Matt Ramsay weighed in today on chip giant Advanced Micro Devices, Inc. (NASDAQ:AMD), summarizing expectations and key topics ahead of earnings on Tuesday, January 31.
Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) constipation drug Trulance will compete directly with Ironwood Pharmaceuticals (NASDAQ:IRWD) and Allergan‘s (NYSE:AGN) drug Linzess, which received FDA approval this …
Canaccord analyst John Newman weighs in on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), as competitor Ironwood Pharmaceuticals (NASDAQ:IRWD) has a PDUFA date of February 9, 2017 for …
Canaccord top analyst Michael Walkley is weighing in on QUALCOMM, Inc. (NASDAQ:QCOM) as the chip maker is currently embroiled in legal battle with …
